Publicaciones en las que colabora con Irene Tadeo (20)

2018

  1. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

    Histology and Histopathology, Vol. 33, Núm. 5, pp. 487-495

  2. Lymph microvascularization as a prognostic indicator in neuroblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 26157-26170

2017

  1. A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors

    Pediatric Blood and Cancer, Vol. 64, Núm. 9

2016

  1. Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

    Oncogene, Vol. 35, Núm. 11, pp. 1423-1432

  2. Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort

    British Journal of Cancer, Vol. 115, Núm. 4, pp. 480-489

  3. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Cancer Letters, Vol. 375, Núm. 2, pp. 384-389

  4. Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors

    Oncotarget, Vol. 7, Núm. 15, pp. 19935-19947

2015

  1. Estudio del armazón arquitectónico y del sistema vascular de los tumores neuroblásticos

    Estudio del armazón arquitectónico y del sistema vascular de los tumores neuroblásticos

  2. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E252-E261

2014

  1. Biotensegrity of the extracellular matrix: Physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy

    Frontiers in Oncology, Vol. 4 MAR

  2. Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging

    Analytical and Bioanalytical Chemistry, Vol. 406, Núm. 24, pp. 5795-5803

  3. Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration

    Neoplasia, Vol. 16, Núm. 6, pp. 471-480

  4. Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: A model in neuroblastoma

    Pediatric Research, Vol. 75, Núm. 2, pp. 302-314

2013

  1. Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion

    PLoS ONE, Vol. 8, Núm. 1

  2. NeuPAT: An intranet database supporting translational research in neuroblastic tumors

    Computers in Biology and Medicine, Vol. 43, Núm. 3, pp. 219-228

  3. TMA vessel segmentation based on color and morphological features: Application to angiogenesis research

    The Scientific World Journal, Vol. 2013

2012

  1. Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview

    Histology and Histopathology, Vol. 27, Núm. 6, pp. 693-705

2011

  1. Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors

    Human Pathology

  2. Comparative study of MLPA-FISH to determine DNA copy number alterations in neuroblastic tumors

    Histology and Histopathology, Vol. 26, Núm. 3, pp. 343-350

2010

  1. Gain of MYCN region in a wilms tumor-derived xenotransplanted cell line

    Diagnostic Molecular Pathology, Vol. 19, Núm. 1, pp. 33-39